🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.70
-1.15 (-8.95%)
At close: Nov 20, 2026

Genomics BioSci & Tech. Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-89.41-39.43-223.1-168.0771.618.74
Depreciation & Amortization
82.0773.4762.5139.3732.5233.23
Other Amortization
2.312.310.850.610.460.73
Loss (Gain) From Sale of Assets
-0.1-2.892.42---65.18
Asset Writedown & Restructuring Costs
6.16-----
Loss (Gain) From Sale of Investments
-18.36-25.1447.0665.29-124.769.31
Loss (Gain) on Equity Investments
--52.7219.5618.8813.46
Stock-Based Compensation
1.56-0.010.630.91-
Provision & Write-off of Bad Debts
2.549.541.44-3.091.86-0.57
Other Operating Activities
-42.63-27.67-5.743.290.19-4.87
Change in Accounts Receivable
-13.7-52.49-20.86-0.78-20.16-6.61
Change in Inventory
-6.59-52.76-132.8-10.82-20.581.84
Change in Accounts Payable
-27.9131.3464.48-10.7313.05-0.51
Change in Unearned Revenue
17.47-10.2630.97-7.281.117.15
Change in Other Net Operating Assets
2.597.198.26-243.81-34.48
Operating Cash Flow
-83.97-86.79-111.77-96.02-21.13-27.76
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-30.52-73.49-193.62-150.26-94.08-93.59
Sale of Property, Plant & Equipment
8.318.07---7.93
Divestitures
------134.84
Sale (Purchase) of Intangibles
-10.15-3.08-3.58-1.11-0.15-1.23
Investment in Securities
3.8812.53-95.29-7123.47-40.42
Other Investing Activities
-23.78-12.53-2.020.63-0.41-55.49
Investing Cash Flow
-105.1-67.84-293.92-157.7428.83-317.64

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-357.09128.965050-
Long-Term Debt Issued
-40152.48147.089035.02
Total Debt Issued
277.31397.09281.44197.0814035.02
Short-Term Debt Repaid
--235.95-50-50--50
Long-Term Debt Repaid
--49.4-15.72-100.32-8.16-7.2
Lease Payments
-7.08-7.43-8.67-6.36-4.34-3.66
Total Debt Repaid
-219.22-285.34-65.72-150.32-8.16-57.2
Net Debt Issued (Repaid)
58.09111.75215.7346.76131.84-22.18
Issuance of Common Stock
166.629-150.465.52-
Common Dividends Paid
----7.1-0-0.04
Other Financing Activities
25.030.01108.68--0.08
Financing Cash Flow
249.74120.75324.41190.06197.35-22.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.01-0.410.83-0.274.46-1.92
Net Cash Flow
61.69-34.29-80.45-63.97209.51-369.45

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-114.49-160.28-305.39-246.28-115.21-121.35
Free Cash Flow Growth
------
Free Cash Flow Margin
-15.46%-22.63%-59.00%-62.17%-27.50%-31.12%
Free Cash Flow Per Share
-1.52-2.21-4.21-3.46-1.81-2.01
Levered Free Cash Flow
-40.56-146.96-257.92-219.64-104.84-123.73
Unlevered Free Cash Flow
-31.04-138.4-253.08-216.68-103.6-122.68
Free Cash Flow After Leases
-121.57-167.71-314.06-252.64-119.54-125

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
14.8514.859.74.791.981.67
Cash Income Tax Paid
--0.020.150.810.01-
Change in Working Capital
-28.13-76.98-49.95-53.61-22.77-32.61